mark@markwwilsonmdpc.com

assistant@markwwilsonmdpc.com

(917) 441-2344

PayPal can be used to send payment for services:

©2018 by Mark W. Wilson, MD, PC. Proudly created with Wix.com

Association of Antipsychotic Treatment With Risk of Unexpected Death Among Children and Youths, Ray et al, JAMA Psychiatry, 2019

February 9, 2019

  • Children and youth 5-24 yo on Medicaid

  • New users of second generation antipsychotic medications (low-dose vs. high dose) for conditions other than psychotic disorders vs. controls using either ADHD meds, antidepressants, or non-antipsychotic mood stabilizers

    • 58,497 new users of antipsychotic medications

      • 28,377 low-dose (66% Risperdal)

      • 30,120 high-dose (34.3% Seroquel, 23.4% Abilify, 6.6% Zyprexa)

    • 189,361 new users of control meds

      • 42.9% ADHD meds (most frequently stimulants)

      • 49.6% antidepressants (most frequently SSRIs)

      • 7.5% mood stabilizers (most frequently anticonvulsants)

  • Person-years of follow-up

    • 123,005 in control group

    • 16,159 in low-dose antipsychotic group

    • 27,354 in high-dose antipsychotic group

  • Unexpected deaths

    • 67 (54.5 per 100,000 person-years) in the control group

      • 67.2% from injuries and deaths from suicides

    • 8 (49.5 per 100,000 person-years) in the low-dose antipsychotic group

    • 40 (146.2 per 100,000 person-years) in the high-dose antipsychotic group

  • Risk after adjustment for covariates

    • Risk of death in the high-dose antipsychotic group 80% greater than in the control group

      • The adjusted hazard ratio for unexpected deaths was 3.51, with 45 excess deaths per 100,000 person-years

      • Cardiovascular and metabolic risk the greatest

    • Risk of death from injury or suicide was not increased (hazard ratio of 1.03)

    • No increased risk of total mortality in low-dose antipsychotic group

       

       

       

       

       

       

       

       

       

Please reload

Our Recent Posts

Below is an updated consent for telehealth; you can obtain the official form from my assistant Eric Scott Kincaid.  I added in the following (listed a...

Updated Consent for Telehealth

March 24, 2020

Hi everyone,

I know you’re all closely watching the new developments in the COVID-19 pandemic and I imagine you’ve seen the recent guidelines that sugg...

COVID-19/coronavirus update

March 15, 2020

For those folks taking lamotrigine (Lamictal), if your generic brand is Taro Pharmaceuticals, there is a recall (due to inactive ingredients that may...

Recall of specific generic brand of lamotrigine (Lamictal)

January 26, 2020

1/1
Please reload

Tags

I'm busy working on my blog posts. Watch this space!

Please reload